“I Was Very Impressed” by Medline (MDLN)’s IPO, Says Jim Cramer

Group 1 - Medline Inc. (NASDAQ:MDLN) recently completed its IPO, raising $6.26 billion, making it the largest IPO of 2025 [2] - The IPO was significantly supported by private equity firms such as Blackstone, Carlyle, and Hellman, which had stakes in the company prior to the IPO [2] - Jim Cramer expressed that while he was impressed by Medline's IPO, he found the stock to be "a little too expensive" at its current valuation [3] Group 2 - Cramer highlighted Medline as a strong company with good growth potential, noting its accelerating growth trajectory [3] - Despite acknowledging Medline's potential, there is a belief that some AI stocks may offer better returns with lower risk [4]